IFAM
ICPT

Institutional & Family Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Institutional & Family Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10
Closed -$1K – 885
2018
Q4 		$1K Buy
+10
New +$1.04K ﹤0.01% 801

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Institutional & Family Asset Management's ICPT Position: Q1 2019 in Review

Institutional & Family Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2019, closing a stake of 10 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in ICPT in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 202 funds tracked by Wall St. Rank hold ICPT as of Q1 2019.

  • Institutional & Family Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Institutional & Family Asset Management sold 10 Intercept Pharmaceuticals, Inc. shares in Q1 2019, an estimated $1K.
  • Institutional & Family Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2018 and held it in 1 quarter.
  • Institutional & Family Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $1K in Q4 2018.
  • 202 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2019.

Based on Institutional & Family Asset Management's 13F filing for Q1 2019, filed 13 May 2019.